Xylem (NYSE:XYL) Stock Gets Price Target Reduction from UBS Group

Xylem (NYSE:XYL) had its target price lowered by UBS Group from $112.00 to $99.00 in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a neutral rating on the industrial products company’s stock.

A number of other equities research analysts have also recently commented on XYL. Robert W. Baird set a $123.00 price target on Xylem in a report on Wednesday. Stifel Nicolaus dropped their price objective on Xylem from $141.00 to $114.00 and set a “buy” rating for the company in a research note on Wednesday. Royal Bank Of Canada cut their target price on Xylem from $135.00 to $125.00 and set an “outperform” rating for the company in a research report on Wednesday. Mizuho set a $99.00 price target on Xylem in a research note on Wednesday. Finally, The Goldman Sachs Group dropped their price target on Xylem from $160.00 to $138.00 and set a “buy” rating for the company in a research note on Wednesday. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $121.31.

Xylem Stock Up 1.8%

Shares of XYL stock opened at $92.41 on Thursday. The company has a market capitalization of $21.19 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.54 and a beta of 1.00. Xylem has a one year low of $87.40 and a one year high of $152.43. The company’s fifty day moving average price is $105.05 and its 200-day moving average price is $117.57. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.39 and a quick ratio of 1.24.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, October 27th. The industrial products company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). The firm had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.28 billion. Xylem had a net margin of 11.94% and a return on equity of 12.06%. The firm’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.37 EPS. Sell-side analysts expect that Xylem will post 5.45 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were paid a $0.43 dividend. The ex-dividend date was Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.9%. Xylem’s payout ratio is presently 38.05%.

Insider Activity at Xylem

In other news, Director D Koch acquired 11,000 shares of the business’s stock in a transaction dated Thursday, October 29th. The stock was purchased at an average price of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the transaction, the director directly owned 12,247 shares in the company, valued at approximately $1,097,331.20. This trade represents a 882.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.32% of the stock is owned by company insiders.

Institutional Investors Weigh In On Xylem

Several large investors have recently made changes to their positions in the company. Pathway Financial Advisers LLC increased its position in Xylem by 10.8% during the third quarter. Pathway Financial Advisers LLC now owns 15,054 shares of the industrial products company’s stock valued at $1,525,000 after acquiring an additional 1,471 shares during the last quarter. Corbyn Investment Management Inc. MD raised its stake in shares of Xylem by 14.4% in the third quarter. Corbyn Investment Management Inc. MD now owns 55,062 shares of the industrial products company’s stock valued at $5,576,000 after acquiring an additional 6,945 shares during the period. Jmac Enterprises LLC bought a new stake in shares of Xylem in the 3rd quarter worth about $537,000. Covestor Ltd lifted its holdings in shares of Xylem by 38.5% in the 3rd quarter. Covestor Ltd now owns 583 shares of the industrial products company’s stock worth $59,000 after acquiring an additional 162 shares during the last quarter. Finally, Markel Group Inc. bought a new stake in shares of Xylem in the 3rd quarter worth about $1,244,000. 87.96% of the stock is owned by institutional investors.

Key Stories Impacting Xylem

Here are the key news stories impacting Xylem this week:

• Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
• Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
• Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
• Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
• Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
• Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.